Targeted RNA drug company Undecimal Bio raises EUR 16 million in… – Funding News

News brief

Targeted RNA drug company Undecimal Bio completed EUR 16 million in seed funding from 4BIO Capital, IQ Capital and others.

Sources · 1

English text is maintained separately from the original record. Consult the original source before citing a fact.

Original source text

Names may use phonetic renderings when no English name is supplied. The original wording is retained below.

靶向RNA药物公司Undecimal Bio完成1600万欧元种子轮融资，由4BIO Capital、IQ Capital等投资。